SCHEMBL13643207

SCHEMBL13643207

c1ccc2c(-c3cc(-c4cccc5ccccc45)c4cc(-c5ccc(-c6nc7ccccc7o6)cc5)c5ccccc5c4n3)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ ALDH1A1 P00352 6/20 0.45
▸ HPGD P15428 5/20 0.45
▸ HSD17B10 Q99714 5/20 0.45
▸ TP53 P04637 3/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ ATM Q13315 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ ESR1 P03372 2/20 0.44
▸ ESR2 Q92731 2/20 0.44
▸ USP2 O75604 2/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13642894 1.00 NPC1 (0.46) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13643034 0.93 NPC1 (0.48) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13642748 0.87 NPC1 (0.46) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13643052 0.87 NPC1 (0.46) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13642869 0.84 NPC1 (0.50) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13643183 0.84 NPC1 (0.50) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13643008 0.84 NPC1 (0.50) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13642963 0.83 NPC1 (0.49) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13643109 0.83 NPC1 (0.49) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL13642815 0.83 NPC1 (0.49) NPC1RAB9AALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 — — US disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 — — US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 — — US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, AOX1, OR10J3 NPC1 1529/4885RAB9A 2608/4885ALDH1A1 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback